Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV sequence databases.

Carla Kuiken1, Bette Korber, Robert W Shafer

  • 1Los Alamos National Laboratory, Los Alamos, NM 87545, USA. kuiken@lanl.gov

AIDS Reviews
|July 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios.

Viruses·2026
Same author

Fine-tuning and structured prompting strategies for question answering over full-text biomedical research articles.

PloS one·2026
Same author

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

The lancet. HIV·2026
Same author

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.

Communications medicine·2026
Same author

Plasma Extracellular Vesicle Surface Marker Profiling Reveals Immune Cell-Associated Mitochondrial Membrane Potential Alterations in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Open forum infectious diseases·2026
Same author

Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.

Science (New York, N.Y.)·2026
Same journal

Systematic review and meta-analysis of risk prediction models for HIV testing in key populations.

AIDS reviews·2026
Same journal

Hantavirus outbreak in a cruise departing from Argentina.

AIDS reviews·2026
Same journal

Dolutegravir shows efficacy in HTLV-1 infection.

AIDS reviews·2026
Same journal

Global research landscape of two-drug regimens for HIV treatment: a visual bibliometric analysis.

AIDS reviews·2026
Same journal

Antiretroviral therapy "à la carte".

AIDS reviews·2026
Same journal

Can Google <i>DeepMind</i> unlock the mystery of life's origin?

AIDS reviews·2026
See all related articles

Two key databases support HIV genetic research: the Los Alamos HIV Sequence Database for comprehensive sequence data and analysis, and the Stanford HIV RT/Protease Sequence Database for analyzing drug resistance. Both offer valuable tools and data for researchers.

Area of Science:

  • Virology
  • Bioinformatics
  • Genetics

Background:

  • Human Immunodeficiency Virus (HIV) genetic research relies on specialized databases for sequence data and analysis.
  • Two prominent databases, the Los Alamos HIV Sequence Database and the Stanford HIV RT/Protease Sequence Database, serve distinct but complementary roles.

Purpose of the Study:

  • To provide a detailed overview of the data types, services, and operational frameworks of two major HIV genetic research databases.
  • To highlight the specific contributions and functionalities of the Los Alamos and Stanford databases in HIV research.

Main Methods:

  • Descriptive analysis of the content and features of the Los Alamos HIV Sequence Database.
  • Descriptive analysis of the content and features of the Stanford HIV RT/Protease Sequence Database.

Related Experiment Videos

  • Comparative overview of data collection, annotation, analysis tools, and operational models.

    • Main Results:

    • The Los Alamos HIV Sequence Database offers comprehensive sequence collection, annotation, and general data analysis.
    • The Stanford HIV RT/Protease Sequence Database specializes in sequences related to anti-retroviral drug resistance, focusing on resistance analysis.
    • Both databases provide distinct yet essential resources for understanding HIV genetic diversity and drug resistance.

    Conclusions:

    • These databases are crucial resources for advancing HIV genetic research, drug development, and treatment strategies.
    • Understanding the specific offerings of each database allows researchers to leverage the most appropriate tools for their studies.
    • Continued development and accessibility of these databases are vital for ongoing efforts to combat HIV/AIDS.